Cyclooxygenase-2 and Survivin in Superficial Urothelial Carcinoma of the Bladder and Correlation with Intratumoural Microvessel Density

By Yildirim U   Erdem H   Kayikci A   Sahin AF   Uzunlar AK   Albayrak A  

The Journal of International Medical Research, Vol. 38, Iss. 5, 2010-09 ,pp. : 1689-1699

Field House Publishing

Access to resources Recommend Favorite

Quality of diagnostic staging in patients with bladder cancer: A process-outcomes link

By Chamie Karim   Ballon-Landa Eric   Bassett Jeffrey C.   Daskivich Timothy J.   Leventhal Meryl   Deapen Dennis   Litwin Mark S.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 379-385

Blackwell Publishing

Access to resources Recommend Favorite

The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer

By Abern Michael R.   Terris Martha K.   Aronson William J.   Kane Christopher J.   Amling Christopher L.   Cooperberg Matthew R.   Freedland Stephen J.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1656-1662

Blackwell Publishing

Access to resources Recommend Favorite

Intravesical valrubicin in the treatment of carcinoma in situ of the bladder

By Steinberg GD   Kuznetsov DD   O’Connor RC   Alsikafi NF  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1009-1013

Informa Healthcare

Access to resources Recommend Favorite

Contemporary Intravesical Treatment Options for Urothelial Carcinoma of the Bladder

By Brassell Stephen A.   Kamat Ashish M.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 10, 2006-11 ,pp. : 1027-1036

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite